preloader

DRUG PRICE CONTROL REVIEW COMMITTEE

Government of India
Ministry of Chemicals & Fertilizers
Department of Chemicals and Petrochemicals
—————————–

No.5(1)/98-PI.I

                       New Delhi, the 31st March, 1999

Memorandum

It has been decided to constitute a Drug Price Control Review Committee to review the current drug price control mechanism and to suggest alternative models, if any with a view to reduce the rigours of price control where they have become counter productive. Accordingly, the following Committee is constituted: –

  1. 1. Secretary, Department of C&PC Chairman

2. Additional Secretary, Member

3. Ministry of Health & F.W.

4. Dr. D.B. Gupta Member

5. Dr. H. Khorakiwala Member

6. Dr. Rakesh Mohan Member

7. Dr. Amit Mitra Member

8. Joint Secretary, (P.I) Member

9 Chairman, N.P.P.A. Member

10. Drug Controller General of India Member

11. Dr. Mira Shiva Member

12. OSD, Deptt. of C&PC Convenor/Member

    1. The terms of reference of the Committee will be:-
      1. To review the current Drug Price Control Mechanism and suggest alternative models, if any
      2. To suggest the criteria of market competition and monopoly and turnover for inclusion of drugs under price control and,
      3. To suggest measures for improving quality of products within the drugs price control mechanism.
      4. To suggest pricing policies for newer generation of drugs, new drug delivery systems and non-prescription drugs.
    1. The Committee will liase closely with the Pharmaceutical Research and Development Review Committee.
    2. The Committee will be free to associate/consult any industry associations/ leading pharmaceutical manufacturers, consumer groups, experts and other interest groups etc., in finalizing its report.
    3. The Committee shall submit its report within three months.

  1. (S.K. SOOD)
    Joint Secretary to the Government of India

     

    Copy to :
    The Secretary,
    Department of Chemicals & Petrochemicals,
    Shastri Bhavan,
    New Delhi.
    Dr. D.B. Gupta
    Chairman & Managing Director,
    M/s Lupin Laboratories Ltd.,
    159, CST Road,
    Kalina, Santacrust East,
    Mumbai – 400 098.

    --

    Dr. H.F. Khorakiwala
    Chairman & Managing Director,
    M/s Wockhardt Ltd.,
    Pharma Search House,
    72/73, Worli Hill Estate,
    B.G. Kher Marg,
    Worli, Mumbai – 400 018.
    Dr. Rakesh Mohan
    Director General,
    National Council for Applied Economic Research,
    Parishila Bhavan,
    11, I.P.Estate,
    New Delhi.

    --

    Dr. Amit Mitra
    Secretary General,
    F.I.C.C.I.
    Federation House,
    Tansen Marg,
    New Delhi – 110 001.
    The Joint Secretary, (P.I.)
    Department of Chemicals & Petrochemicals,
    Shastri Bhavan,
    New Delhi.

    --

    The Chairman
    National Pharmaceutical Pricing Authority,
    Jawahar Vyapar Bhavan,
    New Delhi.
    Dr. Das Gupta
    Drug Controller General of India,
    Nirman Bhavan,
    New Delhi.

    --

    Dr. Mira Shiva
    Head of Department,
    Department of Public Policy,
    B-40, Qutab Institutional Area,
    Behind Qutab Hotel,
    New Delhi – 110 016.
    Officer on Special Duty
    Department of Chemicals & Petrochemicals,
    Shastri Bhavan,
    New Delhi.

    --

    The Additional Secretary,
    Ministry of Health & F.W.,
    Nirman Bhavan,
    New Delhi.
     –

    (S.K. SOOD)

    Joint Secretary to the Government of India

Last Page Updated: 31-10-2018